Preprint · CC-BY
via OpenAlex
Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment
Anna A. M. Miller, Bo Lin, Matthew R. Pincus, Eugene J. Fine, Richard David Feinman
bioRxiv (Cold Spring Harbor Laboratory) · 2021 · ▲ 2 citations
Abstract
Abstract Background The potential for ketogenic diets or administration of exogenous ketone bodies to treat or prevent to cancer remains encouraging. Of particular interest is the possibility that, whatever the effect of a nutritional intervention alone, the diet might enhance the effect of existing cancer drugs, thereby requiring lower doses and a reduction in toxicity and side effects. Methods SW480, a human cell line derived from colon, was treated with ketone bodies (sodium 3-hydroxy butyrate (common name, □-hydroxy butyrate) or with sodium acetoacetate in the presence or absence of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition). Cells were incubated for 96 hours in DMEM with 10 mM glucose medium. HSF2617, a human epithelial fibroblast line served as control and cells were subjected to similar treatment as the SW480 cells. Cell proliferation and glucose consumption were determined with standard reagents. Results The ketone bodies inhibited proliferation of SW480 cells in culture. Rapamycin also inhibited proliferation and its action was enhanced by the ketone bodies although there was little synergistic effect under these conditions. Human fibroblast controls were not inhibited by the ketone bodies. Both SW480 and control lines showed consumption of glucose during a 96 hour incubation period, suggesting that normal controls can switch to ketogenic metabolism while the cancer cells, which proliferate poorly, cannot. Results are consistent with recent reports of a mouse model showing the synergy of rapamycin and a ketogenic diet (Zou Y, et al . (2020) PLoS ONE 15 (5)) as well as earlier publications describing additive or synergistic effects of ketogenic diets with other modalities of cancer treatment. Conclusions The results show that the growth of a cancer cell line in culture can be inhibited by the addition of ketone bodies or rapamycin to the growth medium. The combination of treatments was found to be additive, consistent with results from a previously published mouse model. The data demonstrate the potential for a strategy whereby doses of anti-cancer agents that have detrimental or toxic side-effects can be reduced if coupled to an appropriate source of ketone bodies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2021.06.27.450024
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Miller, A.A.M., Lin, B., Pincus, M.R., Fine, E.J., & Feinman, R.D. (2021). Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2021.06.27.450024
Vancouver
Miller AAM, Lin B, Pincus MR, Fine EJ, Feinman RD. Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment. bioRxiv (Cold Spring Harbor Laboratory). 2021. doi:10.1101/2021.06.27.450024.
BibTeX
@unpublished{anna2021Inhibi,
title = {Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment},
author = {Anna A. M. Miller and Bo Lin and Matthew R. Pincus and Eugene J. Fine and Richard David Feinman},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2021},
doi = {10.1101/2021.06.27.450024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2020
Open access · CC-BY
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
The Effect of a Ketogenic Diet and Synergy with Rapamycin in a Mouse Model of Breast Cancer
Clinical Colorectal Cancer 2020
Open access · CC-BY
Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease
Cancers 2023
Open access · CC-BY
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
Journal of Advanced Research 2024
Open access · CC-BY